CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices GALWAY, Ireland and WASHINGTON, March 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...
Read More Details
Finally We wish PressBee provided you with enough information of ( SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients )
Also on site :
- Uno de los médicos acusados de suministrar ketamina a Matthew Perry acepta declararse culpable, según muestra el documento
- ‘Like the world has forgotten us:’ As Iran-Israel conflict escalates, Gazans fear their suffering will become invisible
- In Q1 2025, enterprise SaaS M&A deal count hit 210, according to PitchBook